IP Library Granted Patent US 6,908,609
Granted Patent B2
US 6,908,609 · App. 10/036,989 · Granted Jun 21, 2005

In vivo use of water absorbent polymers

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,908,609
App. No.
10/036,989
Granted
Jun 21, 2005
Kind
B2
Abstract

The subject invention is a method and material for removing fluid from the intestinal tract of a host and may be useful in treating animals or human patients suffering from fluid overload states. In one embodiment, the subject method involves ingesting an enterically coated non-systemic, non-toxic, non-digestible, water absorbing polymer which absorbs fluid while passing through the intestinal tract. The polymer is excreted in the feces wherein the polymer and absorbed fluid is removed from the body. Preferred polymers include super absorbent acrylic acid polymers, preferably provided in bead form. The polymers may include functional groups for selectively removing blood borne waste products, e.g. urea, from the G.I. tract.

Claims (16)

1. A method for removing fluid from the intestinal tract of a host by directly delivering an effective amount of an enterically-coated water-absorbent polymer to the intestinal tract wherein the polymer absorbs at least about 20 times its weight in physiological saline.

2. The method of claim 1 wherein the method of delivery is oral administration.

3. The method of claim 1 wherein the polymer absorbs at least 30 times its weight in physiological saline.

4. The method of claim 3 wherein the polymer absorbs at least 40 times its weight in physiological saline.

5. The method of claim 1 wherein the polymer is formed by polymerizing acrylate containing monomers.

6. The method of claim 1 wherein the polymer is formed by polymerizing monomer comprising acrylic acid or salts thereof.

7. The method of claim 1 wherein the polymer is a polysaccharide.

8. The method of claim 1 wherein the polymer includes functional groups for selectively absorbing blood borne waste products.

9. The method of claim 8 wherein the polymer includes functional groups for selectively absorbing urea.

10. The method of claim 8 wherein the polymer includes functional groups for selectively absorbing phosphate.

11. The method of claim 2 wherein the enteric coating is selected from at least one of: hydroxypropylmethylcellulose, hydroxypropylmethylcellulose phthalate, methacrylic acid polymers, or polymers of derivatives of methacrylic acid.

12. The method of claim 2 wherein the polymer is placed within an enterically coated capsule.

13. The method of claim 12 wherein the enteric coating is selected from at least one of: hydroxypropylmethylcellulose, hydroxypropylmethylcellulose phthalate, methacrylic acid polymers , or polymers of derivatives of methacrylic acid.

14. A method for treating fluid overload states in a host by directly delivering an effective amount of an enterically-coated water-absorbent polymer to the intestinal tract wherein the polymer absorbs at least about 20 times its weight in physiological saline.

15. The method of claim 14 wherein the method of delivery is oral administration.

16. The method of claim 14 wherein the fluid overload state is selected from at least one of: edema, congestive heart failure, ascites, and renal insufficiency.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Sep 2, 2016
From: CANTOR FITZGERALD SECURITIES
To: RELYPSA, INC.
Reel/Frame 039621/0142 →
SECURITY INTEREST Recorded Apr 27, 2016
From: RELYPSA, INC.
To: CANTOR FITZGERALD SECURITIES
Reel/Frame 038394/0034 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2016
From: SORBENT THERAPEUTICS, INC.
To: UECKER & ASSOCIATES, INC.
Reel/Frame 037924/0444 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2016
From: UECKER & ASSOCIATES, INC.
To: RELYPSA, INC.
Reel/Frame 038040/0029 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2006
From: DOW GLOBAL TECHNOLOGIES INC.
To: SORBENT THERAPEUTICS, INC.
Reel/Frame 017297/0182 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2005
From: THE DOW CHEMICAL COMPANY
To: DOW GLOBAL TECHNOLOGIES INC.
Reel/Frame 015719/0390 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2005
From: SIMON, JAMIE; STRICKLAND, ALAN D.
To: THE DOW CHEMICAL COMPANY
Reel/Frame 015719/0475 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2005
From: THE DOW CHEMICAL COMPANY
To: DOW GLOBAL TECHNOLOGIES INC.
Reel/Frame 015719/0487 →